ALC

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Alcon, Inc.

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.
CEO
David J. Endicott
Employees
20000
Headquarters

rue Louis-d'Affry 6
http://www.alcon.com

News

Mizuho lifts Alcon stock target on strong lens outlook
May 16, 2024 11:35am

https://www.investing.com/news/company-news/mizuho-lifts-alcon-stock-target-on-strong-lens-outlook-93CH-3443780


Source:Investing.com
Contact Lens Maker Alcon''s Has New Growth Avenues, Analyst Upgrades Stock
May 15, 2024 18:35pm

Oppenheimer has upgraded Alcon Inc (NYSE: ALC ) following firm first-quarter earnings and several new drivers coming into view. The analyst sees a new opportunity in glaucoma with the announced acquisition of BELKIN Vision for $60 million immediately and up to $335 million with milestone payments. Via the BELKIN Vision deal, Alcon adds FDA-approved Eagle direct-SLT for glaucoma. Selective Laser Trabeculoplasty (SLT) stimulates the trabecular meshwork to increase fluid drainage/lower Intraocular pressure (IOP). The analyst also writes that Eagle has differentiating characteristics including shorter treatment time. Once closed, BELKIN will broaden ALC’s reach into glaucoma treatment. The analyst also highlights: The … Full story available on Benzinga.com


Source:Benzinga
Oppenheimer raises Alcon to outperform, cites multiple drivers
May 15, 2024 14:24pm

No summary available.


Source:Seeking Alpha
Alcon Analysts Increase Their Forecasts Following Q1 Results
May 15, 2024 12:13pm

Alcon Inc . (NYSE: ALC ) posted mixed first-quarter financial results, after the closing bell on Monday . Alcon posted adjusted earnings of 78 cents per share, beating market estimates of 73 cents per share. The company''s quarterly sales came in at $2.444 billion, versus expectations of $2.462 billion, according to data from Benzinga Pro . “Our first-quarter results reflect the outstanding work done by our more than 25,000 associates across both … Full story available on Benzinga.com


Source:Benzinga
Alcon shares target raised by Baird on growth prospects
May 15, 2024 10:46am

https://www.investing.com/news/company-news/alcon-shares-target-raised-by-baird-on-growth-prospects-93CH-3441416


Source:Investing.com
Unveiling Alcon (ALC)''s Value: Is It Really Priced Right? A Comprehensive Guide
May 15, 2024 01:14am

Unveiling Alcon (ALC)''s Value: Is It Really Priced Right? A Comprehensive Guide


Source:GuruFocus
Earnings call: Alcon reports record Contact Lens sales, optimistic outlook
May 14, 2024 18:15pm

https://www.investing.com/news/stock-market-news/earnings-call-alcon-reports-record-contact-lens-sales-optimistic-outlook-93CH-3440148


Source:Investing.com
Alcon Inc''s Meteoric Rise: Unpacking the 16% Surge in Just 3 Months
May 14, 2024 16:17pm

Alcon Inc''s Meteoric Rise: Unpacking the 16% Surge in Just 3 Months


Source:GuruFocus
Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript
May 14, 2024 14:48pm

No summary available.


Source:Seeking Alpha
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
May 14, 2024 12:30pm

Shares of Alcon Inc . (NYSE: ALC ) rose sharply in today''s pre-market trading following better-than-expected first-quarter earnings. Alcon posted adjusted earnings of 78 cents per share, beating market expectations of 63 cents per share. The company''s quarterly sales came in at $2.444 billion versus estimates of $2.462 billion, according to data from Benzinga Pro . Alcon shares jumped 10.8% to $89.40 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers GameStop Corp . (NYSE: GME ) gained 40.2% to $42.70 in pre-market trading after jumping over 74% on Monday. Faraday Future Intelligent Electric Inc . (NASDAQ: FFIE ) gained 39.2% to $0.0849 in pre-market trading after jumping over 32% on Monday. AMC Entertainment Holdings, Inc . (NYSE: AMC ) shares gained 38.3% to $7.18 in pre-market trading after surging 78% on Monday. Warrantee Inc (NASDAQ: WRNT ) rose 31.6% to $0.41 in today''s pre-market trading. MicroCloud Hologram Inc . … Full story available on Benzinga.


Source:Benzinga